DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,284,022 | +10.1% | 2,292,003 | +57.5% | 0.27% | +9.6% |
| Q2 2023 | $42,946,552 | +71.2% | 1,455,322 | +33.7% | 0.25% | +83.1% |
| Q1 2023 | $25,084,524 | -17.2% | 1,088,738 | 0.0% | 0.14% | -25.3% |
| Q4 2022 | $30,277,804 | +67.6% | 1,088,738 | +84.9% | 0.18% | +54.2% |
| Q3 2022 | $18,068,000 | +4.3% | 588,738 | 0.0% | 0.12% | +20.4% |
| Q2 2022 | $17,327,000 | +506.9% | 588,738 | +563.5% | 0.10% | +512.5% |
| Q1 2022 | $2,855,000 | -27.9% | 88,738 | 0.0% | 0.02% | -15.8% |
| Q4 2021 | $3,958,000 | -11.6% | 88,738 | 0.0% | 0.02% | -5.0% |
| Q3 2021 | $4,477,000 | -35.7% | 88,738 | 0.0% | 0.02% | -35.5% |
| Q2 2021 | $6,961,000 | +37.4% | 88,738 | 0.0% | 0.03% | +40.9% |
| Q1 2021 | $5,067,000 | -31.8% | 88,738 | 0.0% | 0.02% | -21.4% |
| Q4 2020 | $7,433,000 | +108.7% | 88,738 | -10.7% | 0.03% | +100.0% |
| Q3 2020 | $3,562,000 | +40.5% | 99,400 | -5.2% | 0.01% | +27.3% |
| Q2 2020 | $2,536,000 | +38.1% | 104,900 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $1,837,000 | – | 104,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $219,569,000 | 28.65% |
| ARCH Venture Management, LLC | 5,168,749 | $152,116,000 | 18.54% |
| Casdin Capital, LLC | 1,500,000 | $44,145,000 | 3.73% |
| Flagship Pioneering Inc. | 2,619,968 | $77,106,000 | 2.90% |
| Yiheng Capital Management, L.P. | 1,014,684 | $29,862,000 | 1.71% |
| SECTORAL ASSET MANAGEMENT INC | 202,100 | $5,948,000 | 1.20% |
| GILDER GAGNON HOWE & CO LLC | 1,956,820 | $57,589,000 | 1.03% |
| Artal Group S.A. | 600,000 | $17,658,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $158,024,002 | 0.87% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $283,000 | 0.69% |